
Release date: 2024-07-09 10:49:30 Article From: Lucius Laos Recommended: 593
As we all know, from the perspective of the universe, our solar system is very small, but from the perspective of the earth, it is very huge, the edge of the solar system is the Oort Nebula, the diameter of light has reached 2 light years, we human beings want to go out of the solar system to find a new home, with the current technology of human beings is almost a fantasy, it will take 18,000 years to fly at the third cosmic speed to reach the edge of the Oort Nebula. We humans are small, but we are extremely destructive to the planet. The environment we live in is slowly dying out at a speed visible to the naked eye, how many 18,000 years have we humans had? Let's take action, for humanity we only have one Earth!

The lonely earth and moon depend on each other
Lucius Pharmaceutical's mission is to save human lives and save the environment ----- planet on which we live! To this end, we at Lucius have launched a tree planting campaign to protect the nature of the earth to the Lao government! Our aim is to awaken humanity to the importance of environmental protection through our activities!
Therefore, Lucius Pharmaceutical, together with the Lao government, the Embassy of the Government of India in Laos, and celebrities from all walks of life held a nature conservation tree planting activity in the Lucius Pharmaceutical Park.

The scene of the Lucius Pharmaceutical Park event
The event was attended by the Ambassador of the Embassy of the Government of India in Laos, the Minister of Land Resources and Environment of Laos, the Deputy Minister of Land Resources and Environment of Laos, the Deputy Minister of Home Affairs of Laos, the Director of the Food and Drug Administration of Laos, the Deputy Director of the Food and Drug Administration, the Director of the Drug Division, the Director of the Water Resources Bureau and other government dignitaries and elites from all walks of life attended the event!

Guests seated at the Lucius Pharmaceutical Park event
At the beginning of the event, we, the CEO of Lucius Pharmaceuticals, read out the Declaration on Earth Conservation. We promise that we at Lucius Pharmaceuticals will do our part to protect the environment we live in!
We have more than 25,000 square meters of open space in Lucius Pharmaceutical Park, and every year it rains, the rain will wash the land in a round, and the soil erosion is serious, so we take this opportunity to plant trees in Lucius Pharmaceutical and government departments!
The Minister of Land, Resources and Environment praised Lucius Pharmaceuticals for its tree-planting campaign to protect the planet and hoped that this tradition would continue.
It is our common responsibility to protect the environment on which mankind depends, regardless of borders, skin colour or gender. Lucius Pharmaceuticals hopes to unite various countries to work together through the Tree Planting Campaign to make our earth breathable!
As it is said in the Wandering Earth, there is only responsibility in the current crisis, and whether we are poor or rich, the earth is our common home. Historically, the fate of humanity has depended on human choices. Human beings, a small race born in the solar system, have created its splendid civilization, and Lucius Pharmaceutical is one of the small participants in this civilization.
Company Overview: Industrial Migration from India to LaosLucius Pharmaceuticals (Laos) Co., Ltd. was established in 2020, with its headquarters located at No. 26, Thongmang Village···【more】
Recommended:39Release date: 2026-07-20
Lucius Pharmaceutical is one of the representative generic drug enterprises in Laos. The company was established in Vientiane, the capital of Laos, in 2020 and has been in operatio···【more】
Recommended:60Release date: 2026-07-17
Industrial Rise: From Zero to a "World Pharmacy" CandidateThe explosive growth of Laos' generic drug industry is rooted in unique international rule dividends. As a U···【more】
Recommended:76Release date: 2026-07-16
In recent years, Laos generic drugs have gradually come into view of oncology and chronic disease patients in China due to their significant price advantage. Leveraging the WTO pat···【more】
Recommended:81Release date: 2026-07-15
Regulatory System: From "One Ministry, One Department" to Legal AmendmentsLao drug regulation adopts a centralized "one ministry, one department" management mod···【more】
Recommended:89Release date: 2026-07-14
Overview of Lao generic drug industryThe Lao generic drug industry started late but has developed rapidly in recent years. Relying on the WTO's patent waiver for least develope···【more】
Recommended:92Release date: 2026-07-09
Laos's pharmaceutical industry started late and remains relatively small in scale; for a long time, domestic drug supply has relied on imports from China, India, and other coun···【more】
Recommended:100Release date: 2026-07-08
Before 2020, there were only a handful of legally approved local pharmaceutical manufacturers in Laos, mostly small state-owned factories with outdated equipment. Within just a few···【more】
Recommended:111Release date: 2026-07-07
With generic drugs as its core, Laos' pharmaceutical industry has formed an industrial pattern featuring coordination between state-owned and private enterprises as well as loc···【more】
Recommended:127Release date: 2026-07-02
The pharmaceutical industry in Laos started late and is limited in scale, with domestic drug supply long relying on imports of quality generic medicines from China, India and other···【more】
Recommended:1117Release date: 2026-07-01
Lucius Pharmaceuticals (Lao) Co., Ltd is a Lao pharmaceutical company established in 2020, headquartered in Vientiane, the capital of Laos. Despite its short history, the company h···【more】
Recommended:154Release date: 2026-06-30
The Lao generic pharmaceutical industry has developed rapidly in recent years, attracting increasing attention from patients worldwide. As one of the least developed countries in S···【more】
Recommended:442Release date: 2026-06-29
Dr. Louis, a microbiologist at the World Health Organization (WHO), recently made a technical visit to Lucius Pharmaceuticals in Laos. The purpose of the visit was to learn more ab···【more】
Recommended:798Release date: 2024-07-09
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and mortality, which has been troubling medical workers. Clinical studies have foun···【more】
Recommended:756Release date: 2024-07-09
Lucius version of Dacomitinib is now availableCutaneous adverse reactions and management strategies for DacomitinibRash and exfoliative skin reactions are highly characteristic adv···【more】
Recommended:20Release date: 2026-07-21
Lao PDR: Filgotinib Has Been LaunchedBefore initiating filgotinib treatment, strict screening for the following contraindications is mandatory; the presence of any one of these con···【more】
Recommended:74Release date: 2026-07-13
Lucius Pharmaceuticals' Pirtobrutinib Has Been LaunchedPirtobrutinib is an oral anticancer drug whose active ingredient is pirtobrutinib, belonging to the class of Bruton's···【more】
Recommended:97Release date: 2026-07-10
Lucius Pharmaceuticals (Lao) Co., Ltd. has launched a generic version of elagolix sodium (trade name LuciElag) for the treatment of moderate to severe pain associated with endometr···【more】
Recommended:94Release date: 2026-07-06
Contraindications for Bempedoic Acid (Nilemdo)Bempedoic acid (Nilemdo) is strictly contraindicated in the following situations: ①hypersensitivity to bempedoic acid or any excipient···【more】
Recommended:109Release date: 2026-07-03
MONDAY, June 15, 2026 — A study published online June 8 in Nature Medicine has found that apitegromab, through its selective inhibition of myostatin, can maintain lean body mass wh···【more】
Recommended:141Release date: 2026-06-24
On May 28, 2026, AstraZeneca announced that its immunotherapy drug Imfinzi (durvalumab) in combination with BCG (Bacillus Calmette-Guérin) induction and maintenance regimen has rec···【more】
Recommended:255Release date: 2026-06-01
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizumab (Keytruda, Merck & Co., Inc.) or pembrolizumab and berahyaluronidase alf···【more】
Recommended:574Release date: 2025-12-17
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination with abiraterone acetate (brand name: Akeega, Janssen Biotech, Inc.) plus predni···【more】
Recommended:518Release date: 2025-12-15
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubicel-onlv), the first hematopoietic stem cell transplantation (HSCT) therapy for th···【more】
Recommended:547Release date: 2025-12-10
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (Breyanzi, developed by Juno Therapeutics, a subsidiary of Bristol Myers Squibb) ···【more】
Recommended:524Release date: 2025-12-08
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobrutinib (Jaypirca, Eli Lilly and Company) for the treatment of adult patients with r···【more】
Recommended:600Release date: 2025-12-04

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com

Name: Lucius

Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643